Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects.
暂无分享,去创建一个
J. Isaacsohn | B. Gordon | S. Weiss | M. Davidson | S. Burke | M H Davidson | M A Dillon | S K Burke | B Gordon | P Jones | J Samuels | S Weiss | J Isaacsohn | P Toth | J. Samuels | P. Jones | P. Toth | M. Dillon | M. H. Davidson | P. Jones | B. Gordon | Julie Samuels | Jonathon Isaacsohn | Maureen A. Dillon
[1] M. Eriksson,et al. Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels , 1990, Journal of internal medicine.
[2] J J Albers,et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.
[3] A. Gotto,et al. Currently available hypolipidaemic drugs and future therapeutic developments. , 1995, Bailliere's clinical endocrinology and metabolism.
[4] W. Martin,et al. Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality. , 1978, Journal of chronic diseases.
[5] D. Hunninghake,et al. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia. , 1981, Metabolism: clinical and experimental.
[6] S. Grundy,et al. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. , 1971, The Journal of laboratory and clinical medicine.
[7] F. Kummerow,et al. Viewpoint on the Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. , 1993, Journal of the American College of Nutrition.
[8] J. Morgan,et al. The 2D food portion visual , 1996 .
[9] D H Blankenhorn,et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. , 1987, JAMA.
[10] S. J. Smith,et al. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements. , 1989, Clinics in laboratory medicine.
[11] Michelakis Am,et al. Colestipol hydrochloride, a new hypolipidemic drug: a two-year study. , 1975 .
[12] A. Gotto,et al. Choosing the right lipid-regulating agent. A guide to selection. , 1996, Drugs.
[13] J. Webster,et al. Colestipol at varying dosage intervals in the treatment of moderate hypercholesterolaemia. , 1994, British journal of clinical pharmacology.
[14] G. Levine,et al. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. , 1995, The New England journal of medicine.
[15] P. Greenland,et al. Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia. , 1992, The American journal of cardiology.
[16] H. G. Morgan,et al. Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism. , 1980, The New England journal of medicine.
[17] J. Kostis,et al. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease. , 1986, The American journal of cardiology.
[18] D. Hunninghake,et al. Alterations in human serum alkaline phosphatase and its isoenzymes by hypolipidemic agents: colestipol and clofibrate. , 1983, Metabolism: clinical and experimental.
[19] D. Illingworth. How effective is drug therapy in heterozygous familial hypercholesterolemia? , 1993, The American journal of cardiology.
[20] R. Platt,et al. Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? , 1995, The New England journal of medicine.
[21] E. Muls,et al. The efficacy and safety of pravastatin, compared to and in combination with bile acid binding resins, in familial hypercholesterolaemia , 1990, Journal of internal medicine.
[22] W. Kannel,et al. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. , 2020, Annals of internal medicine.
[23] M. Fisher,et al. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. , 1984, Circulation.
[24] A. Hartz,et al. Evaluation of the effectiveness of lipid-lowering therapy (bile acid sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia in veterans. , 1993, The American journal of cardiology.
[25] J. Cleeman,et al. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. , 1993, JAMA.
[26] L. Kuller,et al. SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN , 1986, The Lancet.
[27] Ames,et al. PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA , 2000 .
[28] H. Pan,et al. Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia , 1990, Clinical pharmacology and therapeutics.
[29] S. Azen,et al. Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. , 1990, JAMA.
[30] D. Matthews,et al. Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine. , 1992, BMJ.
[31] P. Greenland,et al. DOSE‐RESPONSE STUDY OF COLESTIPOL TABLETS IN PATIENTS WITH MODERATE HYPERCHOLESTEROLEMIA , 1995, American journal of therapeutics.
[32] L. Wilkins. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994 .
[33] C. V. Linden,et al. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia. , 1982, Archives of internal medicine.
[34] L. Wilkins,et al. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994, Circulation.
[35] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.